Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.76% | 370.18% | |||
| Total Other Revenue | -2.75% | 144.53% | |||
| Total Revenue | -2.76% | 217.63% | |||
| Cost of Revenue | -2.75% | 137.63% | |||
| Gross Profit | 2.75% | -50.74% | |||
| SG&A Expenses | -2.75% | -6.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | 59.78% | |||
| Operating Income | 2.75% | -23.84% | |||
| Income Before Tax | 2.75% | 14.08% | |||
| Income Tax Expenses | -2.66% | 57.21% | |||
| Earnings from Continuing Operations | 2.75% | 13.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -2.73% | -- | |||
| Net Income | 2.75% | 17.90% | |||
| EBIT | 2.75% | -23.84% | |||
| EBITDA | 2.75% | -26.46% | |||
| EPS Basic | 2.94% | 80.90% | |||
| Normalized Basic EPS | 0.00% | 62.26% | |||
| EPS Diluted | 2.94% | 80.90% | |||
| Normalized Diluted EPS | 0.00% | 62.26% | |||
| Average Basic Shares Outstanding | 0.00% | 327.30% | |||
| Average Diluted Shares Outstanding | 0.00% | 327.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
